Recurrent tendinitis after treatment with two different fluoroquinolones

被引:27
作者
Burkhardt, O
Kohnlein, T
Pap, T
Welte, T
机构
[1] Univ Magdeburg, Dept Pulm & Crit Care Med, D-39120 Magdeburg, Germany
[2] Univ Magdeburg, Dept Expt Rheumatol, D-39120 Magdeburg, Germany
关键词
D O I
10.1080/00365540410019390
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Tendinopathies with and without tendon rupture are rare adverse events, occurring mainly following older fluoroquinolones, but recently also to an increasing extent following levofloxacin. We report the first case of tendinitis after treatment with moxifloxacin, and of recurrent tendinitis after treatment with 2 different fluoroquinolones. From these findings we conclude hitherto unexplained class effect of fluoroquinolones in respect of the development of tendinitis.
引用
收藏
页码:315 / 316
页数:2
相关论文
共 12 条
[1]  
Dalhoff A, 1999, Expert Opin Investig Drugs, V8, P123, DOI 10.1517/13543784.8.2.123
[2]   Fluouroquinolone-induced tendinopathy: Also occurring with levofloxacin [J].
Fleisch, E ;
Hartmann, K ;
Kuhn, M .
INFECTION, 2000, 28 (04) :256-257
[3]   Fluoroquinolone-induced tendinopathy: What do we know? [J].
Harrell, RM .
SOUTHERN MEDICAL JOURNAL, 1999, 92 (06) :622-625
[4]   Expanding uses of fluoroquinolones: Opportunities and challenges [J].
Hooper, DC .
ANNALS OF INTERNAL MEDICINE, 1998, 129 (11) :908-910
[6]  
JORGENSEN C, 1991, REV RHUM, V58, P623
[7]   Fluoroquinolone toxicity profiles: A review focusing on newer agents [J].
Lipsky, BA ;
Baker, CA .
CLINICAL INFECTIOUS DISEASES, 1999, 28 (02) :352-364
[8]   Role of newer fluoroquinolones in lower respiratory tract infections (vol 49, pg 709, 2002) [J].
Lode, H ;
Allewelt, M .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (01) :151-154
[9]   Ultrastructure of Achilles tendons of rats treated with ofloxacin and fed a normal or magnesium-deficient diet [J].
Shakibaei, M ;
Pfister, K ;
Schwabe, R ;
Vormann, J ;
Stahlmann, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (02) :261-266
[10]   Toxicity of quinolones [J].
Stahlmann, R ;
Lode, H .
DRUGS, 1999, 58 (Suppl 2) :37-42